Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 398 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Neoadjuvant Strategies for Triple Negative Breast Cancer: Current Evidence and Future Perspectives
Zhenjun Huang, Qing Peng, Luhui Mao, Wenhao Ouyang, Yunjing Xiong, Yujie Tan,Haizhu Chen, Zebang Zhang, Tang Li,Yuanjia Hu,Ying Wang,Wei Zhang,Herui Yao,Yunfang Yu
MedComm – Future Medicineno. 1 (2025): n/a-n/a
Cited0Views0Bibtex
0
0
A Multicenter, Randomized, Open Label, Two Formulation, Crossover Bioequivalence Trial of Doxorubicin Hydrochloride Liposomal Injection in Chinese Patients with Metastatic Breast Cancer
Jingshu Wang,Xiuping Lai,Herui Yao,Hui Yang, Xiaolong Cao, Xiaochen Wang,Ying Wang,Weiqi Nian,Xiaodong Zheng,Qingxiu Mai, Anding Liu, Xiaozhi Lv, Xiaoying Bi, Junyi Chen,Junyan Wu,Suiwen Ye
Journal of Cancer Research and Clinical Oncologyno. 1 (2025): 1-12
Cited0Views0WOSBibtex
0
0
MRI-based Multimodal AI Model Enables Prediction of Recurrence Risk and Adjuvant Therapy in Breast Cancer
Yunfang Yu, Wei Ren, Luhui Mao, Wenhao Ouyang,Qiugen Hu, Qinyue Yao, Yujie Tan, Zifan He,Xiaohua Ban,Huijun Hu, Ruichong Lin, Zehua Wang, Yongjian Chen,Zhuo Wu,Kai Chen,Jie Ouyang, Tang Li, Zebang Zhang, Guoying Liu,Xiuxing Chen, Zhuo Li,Xiaohui Duan, Jin Wang,Herui Yao
Pharmacological research (2025): 107765-107765
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 398

#Citation: 14288

H-Index: 51

G-Index: 117

Sociability: 7

Diversity: 3

Activity: 97

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn